Ondine Biomedical (LON:OBI) Trading Up 2.7% – Time to Buy?

Ondine Biomedical Inc. (LON:OBI) rose 2.7% during trading on Friday . The stock traded as high as C$9.50 and last traded at C$9.50. Approximately 174,269 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 336,312 shares. The stock had previously closed at C$9.25.

Ondine Biomedical Stock Up 2.7%

The company has a current ratio of 1.36, a quick ratio of 8.26 and a debt-to-equity ratio of 25.95. The company has a market capitalization of C$4.92 billion, a P/E ratio of -1.36 and a beta of 0.10. The firm’s 50 day moving average price is C$8.90 and its two-hundred day moving average price is C$11.99.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.